Drug Target Review2025-08-06T13:30:47
Japanese researchers have engineered a new lipid nanoparticle that delivers mRNA to cells five times more effectively, resulting in stronger immune responses and tumour suppression in mice.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-07-10T06:15:00
Contributor Professor Donald E Ingber, Drug Target Review
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2026-09-22T07:00:00
Contributor Luca Lotta, Drug Target Review
2025-05-08T09:00:00
Contributor Ning Ren
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud